You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 DU90% in Queensland and in Australia for the overall NSAID utilization in Concession beneficiaries between 1997 and 2003

From: Non-steroidal anti-inflammatory drugs, Cyclooxygenase-2 inhibitors and paracetamol use in Queensland and in the whole of Australia

Australia DU90%
1997–1999% 2000% 2001% 2002% 2003%
Naproxen* 28 Celecoxib+ 35 Celecoxib+ 40 Celecoxib+ 39 Celecoxib+ 35
Diclofenac** 21 Naproxen* 20 Rofecoxib+ 16 Rofecoxib+ 22 Rofecoxib+ 25
Ketoprofen# 16 Diclofenac** 15 Naproxen* 16 Naproxen* 12 Diclofenac** 12
Piroxicam# 10 Ketoprofen# 9 Diclofenac** 14 Diclofenac** 12 Naproxen* 11
Indomethacin* 7 Piroxicam# 7 Ketoprofen# 7 Ketoprofen# 5 Meloxicam+ 9
Ibuprofen** 6 Ibuprofen** 5    
Queensland DU 90%
1997–1999% 2000% 2001% 2002% 2003%
Naproxen* 27 Celecoxib+ 45 Celecoxib+ 43 Celecoxib+ 40 Celecoxib+ 35
Diclofenac** 20 Naproxen* 14 Rofecoxib+ 16 Rofecoxib+ 22 Rofecoxib+ 26
Ketoprofen# 17 Diclofenac** 13 Naproxen* 10 Diclofenac** 9 Diclofenac** 9
Piroxicam# 12 Ketoprofen# 8 Diclofenac** 10 Naproxen* 9 Meloxicam+ 8
Ibuprofen** 9   Ketoprofen# 5 Ibuprofen** 5 Naproxen* 8
Indomethacin* 5   Ibuprofen** 5 Ketoprofen# 4 Ibuprofen** 5
+ Cox-2 inhibitors ** ns-NSAIDs low risk # ns-NSAIDs high risk * ns-NSAIDs moderate risk